Advanced glycation end products in kidney transplant patients: a putative role in the development of chronic renal transplant dysfunction
- 1 June 2004
- journal article
- review article
- Published by Elsevier in American Journal of Kidney Diseases
- Vol. 43 (6) , 966-975
- https://doi.org/10.1053/j.ajkd.2004.02.008
Abstract
No abstract availableKeywords
This publication has 82 references indexed in Scilit:
- Restriction of Dietary Glycotoxins Reduces Excessive Advanced Glycation End Products in Renal Failure PatientsJournal of the American Society of Nephrology, 2003
- Prevention of diabetic nephropathy in mice by a diet low in glycoxidation productsDiabetes/Metabolism Research and Reviews, 2002
- Advanced glycation end products in children with chronic renal failure and type 1 diabetesPediatric Nephrology, 2002
- Plasma levels of advanced glycation end products in children with renal diseasePediatric Nephrology, 2001
- Advanced glycation end products (AGEs)‐induced expression of TGF‐β1 is suppressed by a protease in the tubule cell line LLC‐PK1Nephrology Dialysis Transplantation, 2001
- Reactive carbonyl compounds related uremic toxicity (“carbonyl stress”)Kidney International, 2001
- The Banff 97 working classification of renal allograft pathologyKidney International, 1999
- Host leukocytes and their products in chronic kidney allograft rejection in ratsTransplant International, 1994
- β2-Microglobulin Modified with Advanced Glycation End Products Induces Interleukin-6 from Human Macrophages: Role in the Pathogenesis of Hemodialysis-Associated AmyloidosisBiochemical and Biophysical Research Communications, 1994
- Relation between Complications of Type I Diabetes Mellitus and Collagen-Linked FluorescenceNew England Journal of Medicine, 1986